Döhner K - Search Results

1

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

Döhner H, Lübbert M, Fiedler W, Fouillard L, Haaland A, Brandwein JM, Lepretre S, Reman O, Turlure P, Ottmann OG, Müller-Tidow C, Krämer A, Raffoux E, Döhner K, Schlenk RF, Voss F, Taube T, Fritsch H, Maertens J. Döhner H, et al. Among authors: dohner k. Blood. 2014 Aug 28;124(9):1426-33. doi: 10.1182/blood-2014-03-560557. Epub 2014 Jul 8. Blood. 2014. PMID: 25006120 Free PMC article. Clinical Trial.

2

Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.

Döhner K, Brown J, Hehmann U, Hetzel C, Stewart J, Lowther G, Scholl C, Fröhling S, Cuneo A, Tsui LC, Lichter P, Scherer SW, Döhner H. Döhner K, et al. Among authors: dohner h. Blood. 1998 Dec 1;92(11):4031-5. Blood. 1998. PMID: 9834205 Free article.

3

Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact.

Döhner K, Schlenk RF, van der Reijden BA, Döhner H. Döhner K, et al. Among authors: dohner h. Leukemia. 2000 Jun;14(6):1154. doi: 10.1038/sj.leu.2401804. Leukemia. 2000. PMID: 10865983 No abstract available.

4

Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22.

Fröhling S, Nakabayashi K, Scherer SW, Döhner H, Döhner K. Fröhling S, et al. Among authors: dohner k, dohner h. Hum Genet. 2001 Apr;108(4):304-9. doi: 10.1007/s004390100498. Hum Genet. 2001. PMID: 11379876

5

Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.

Marcucci G, Caligiuri MA, Döhner H, Archer KJ, Schlenk RF, Döhner K, Maghraby EA, Bloomfield CD. Marcucci G, et al. Among authors: dohner k, dohner h. Leukemia. 2001 Jul;15(7):1072-80. doi: 10.1038/sj.leu.2402159. Leukemia. 2001. PMID: 11455976

6

Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease.

Ringhoffer M, Döhner K, Scheil S, Wilts H, Mertens T, Grimminger W, Döhner H, Bunjes D. Ringhoffer M, et al. Among authors: dohner k, dohner h. Bone Marrow Transplant. 2001 Sep;28(6):615-8. doi: 10.1038/sj.bmt.1703188. Bone Marrow Transplant. 2001. PMID: 11607777

7

Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.

Fröhling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Döhner H, Döhner K; Acute Myeloid Leukemia Study Group, Ulm. Fröhling S, et al. Among authors: dohner k, dohner h. J Clin Oncol. 2002 May 15;20(10):2480-5. doi: 10.1200/JCO.2002.08.155. J Clin Oncol. 2002. PMID: 12011125

8

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

Döhner K, Tobis K, Ulrich R, Fröhling S, Benner A, Schlenk RF, Döhner H. Döhner K, et al. Among authors: dohner h. J Clin Oncol. 2002 Aug 1;20(15):3254-61. doi: 10.1200/JCO.2002.09.088. J Clin Oncol. 2002. PMID: 12149299 Clinical Trial.

9

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

Fröhling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K; AML Study Group Ulm. Acute myeloid leukemia. Fröhling S, et al. Among authors: dohner k, dohner h. Blood. 2002 Dec 15;100(13):4372-80. doi: 10.1182/blood-2002-05-1440. Epub 2002 Aug 8. Blood. 2002. PMID: 12393388 Free article.

10

Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.

Schlenk RF, Benner A, Hartmann F, del Valle F, Weber C, Pralle H, Fischer JT, Gunzer U, Pezzutto A, Weber W, Grimminger W, Preiss J, Hensel M, Fröhling S, Döhner K, Haas R, Döhner H; AML Study Group Ulm (AMLSG ULM). Schlenk RF, et al. Among authors: dohner k, dohner h. Leukemia. 2003 Aug;17(8):1521-8. doi: 10.1038/sj.leu.2403009. Leukemia. 2003. PMID: 12886238 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page